Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.011 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
2011A phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adultsMinassian, AM; Rowland, R; Beveridge, NE; Poulton, ID; Satti, I; Harris, S; Poyntz, H; Hamill, M; Griffiths, K; Sander, CR; Ambrozak, DR; Price, DA; Hill, BJ; Casazza, JP; Douek, DC; Koup, RA; Roederer, M; Winston, A; Ross, J; Sherrard, J; Rooney, G; Williams, N; Lawrie, AM; Fletcher, HA; Pathan, AA; McShane, H
2009Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from mycobacterium tuberculosisSmith, SG; Joosten, SA; Verscheure, V; Pathan, AA; McShane, H; Ottenhoff, THM; Dockrell, HM; Mascart, F
2009Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: Comparison with boosting with a new TB vaccine, MVA85AWhelan, KT; Pathan, AA; Sander, CR; Fletcher, HA; Poulton, I; Alder, NC; Hill, AVS; McShane, H
2007Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: Different boosting intervals and implications for efficacy trialsPathan, AA; Sander, CR; Fletcher, HA; Poulton, I; Alder, NC; Beveridge, NER; Whelan, KT; Hill, AVS; McShane, H
2011Th1/Th17 Cell Induction and Corresponding Reduction in ATP Consumption following Vaccination with the Novel Mycobacterium tuberculosis Vaccine MVA85AGriffiths, KL; Pathan, AA; Minassian, AM; Sander, CR; Beveridge, NER; Hill, AVS; Fletcher, HA; McShane, H
2012A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicityRowland, R; Brittain, N; Poulton, ID; Minassian, AM; Sander, C; Porter, DW; Satti, I; Pathan, AA; Lawrie, AM; McShane, H; Williams, N
2009Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in mycobacterium tuberculosis–infected individualsSander, CR; Pathan, AA; Beveridge, NER; Poulton, I; Minassian, A; Alder, N; Van Wijgerden, J; Hill, AVS; Gleeson, FV; Davies, RJO; Pasvol, G; McShane, H
2013Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85AMatsumiya, M; Stylianou, E; Griffiths, K; Lang, Z; Meyer, J; Harris, SA; Rowland, R; Minassian, AM; Pathan, AA; Fletcher, H; McShane, H